Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × vanucizumab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Other solid neoplasm 1 Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Oxaliplatin 1397 Fluorouracil 1289 Capecitabine 1074 Gemcitabine 1034 Leucovorin 921 Irinotecan 811 Bevacizumab 793 Cisplatin 660 Radiotherapy 531 Cetuximab 466 pembrolizumab 427 Paclitaxel 385 Nivolumab 333 130-nm albumin-bound paclitaxel 319 Drug Therapy 309 Docetaxel 286 S 1 (combination) 271 Sorafenib 266 Albumin-Bound Paclitaxel 258 Folfox protocol 254 durvalumab 209 sintilimab 208 Surgical Procedures, Operative 202 Radiosurgery 201 lenvatinib 200 tislelizumab 198 apatinib 197 Carboplatin 185 regorafenib 179 Magnetic Resonance Spectroscopy 178

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02141295 2020-03-25

McCAVE

Hoffmann-La Roche

Phase 2 Terminated

197 enrolled 24 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡